Condition
Endometrial Stromal Sarcoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Endometrial Stromal Sarcoma clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Elacestrant for ER-positive uterine sarcomas
This trial tests whether the oral drug elacestrant can slow or stop growth in people with advanced estrogen receptor–positive uterine sarcomas.
-
MASCT-I plus doxorubicin and ifosfamide as first-line treatment for advanced soft tissue sarcoma
This trial will test whether adding MASCT-I to standard chemotherapy (doxorubicin and ifosfamide) helps adults with advanced soft tissue sarcoma respond better or live longer.
Related topics
Quick answers
How many Endometrial Stromal Sarcoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.